Detalhe da pesquisa
1.
Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer.
Breast Cancer Res Treat
; 192(1): 163-173, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35022867
2.
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer.
Breast Cancer Res Treat
; 189(1): 177-185, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34169393
3.
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study.
Oncologist
; 25(8): e1158-e1169, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452601
4.
Circulating tumor cells in newly diagnosed inflammatory breast cancer.
Breast Cancer Res
; 17: 2, 2015 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25572591
5.
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer.
Breast Cancer Res Treat
; 146(1): 145-52, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24903226
6.
Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancer.
Cancer Invest
; 32(9): 439-44, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25254601
7.
Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer.
Transl Breast Cancer Res
; 5: 10, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751670
8.
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.
J Clin Oncol
; : JCO2302344, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38833643
9.
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma.
Breast Cancer Res Treat
; 141(3): 429-35, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24068539
10.
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
J Clin Oncol
; 41(24): 4004-4013, 2023 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207300
11.
Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer?
Oncologist
; 17(12): 1541-6, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22622148
12.
Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer.
Front Oncol
; 12: 1061789, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36703796
13.
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells.
Int J Cancer
; 129(2): 417-23, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20857493
14.
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.
JAMA
; 305(18): 1873-81, 2011 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21558518
15.
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials.
Lancet Oncol
; 11(4): 358-65, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20189874
16.
Alterations of the 70 kDa heat shock protein (HSP70) and sequestosome-1 (p62) in women with breast cancer.
Sci Rep
; 11(1): 22220, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34782665
17.
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer.
NPJ Breast Cancer
; 7(1): 108, 2021 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34426581
18.
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study.
Clin Cancer Res
; 27(11): 3061-3068, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33727258
19.
Endocrine Therapy-related Endocrinopathies-Biology, Prevalence and Implications for the Management of Breast Cancer.
Oncol Hematol Rev
; 16(1): 17-22, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33841882
20.
Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531.
Elife
; 92020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32667883